Hema Now: Episode 25: The Future of Childhood Cancer - European Medical Journal

This site is intended for healthcare professionals

Hema Now: Episode 25: The Future of Childhood Cancer

Hematology

Hema Now | Episode 25

In this inspiring episode of Hema Now, Catherine Glass speaks with Rob Pieters, Professor of Pediatric Oncology at Utrecht University; and co-founder of the Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands, the largest dedicated childhood cancer centre in Europe. Pieters shares his personal journey in paediatric oncology, the breakthroughs that have reshaped care, and the vision behind uniting all of the Netherlands’ childhood cancer expertise under one roof. 

Rob Pieters

 

Rob Pieters

Rob Pieters is a Professor of Pediatric Oncology at the University of Utrecht, and was one of the initiators and founders of the Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. This national centre has merged the expertise from all former seven childhood cancer centres in the Netherlands into one place, which is now the largest centre in Europe for the research and treatment of childhood cancers.

 

Timestamps 

0:00 – Introduction 

01:06 – Pieters’ start in paediatric oncology 

01:29 – Biggest breakthroughs in childhood cancers 

02:35 – Parts of Pieters work that bring him the most joy 

03:12 – Lessons learnt from patients or their families  

04:31 – The vision behind the Princess Máxima Center 

08:35 – The impact of the Princess Máxima Center  

10:53 – How is research funding divided? 

12:55 – Evolution of treatments in paediatric oncology 

15:10 – What will it take to achieve 100% cure rate in acute lymphoblastic leukaemia? 

18:55 – President Elect of the European Society for Paediatric Oncology (SIOPE) 

22:20 – One message of hope to families facing childhood cancer 

25:10 – Pieter’s three wishes for healthcare 

 

The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.